The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast-growing and/or high potential Life Sciences businesses operating predominantly in the
The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast-growing and/or high potential Life Sciences businesses operating predominantly in the
IIG has today been Admitted onto London’s AIM. IIG is an investment group that seeks to leverage the expertise and extensive networks of its Board and Advisory Panel in the
Two Shields Investments plc, the AIM quoted investment company with a strategy to build a high-quality portfolio of investments in fast growing and scalable digital and technology enabled businesses.
Two Shields Investments plc, the AIM quoted investment company with a strategy to build a high-quality portfolio of investments in fast-growing and scalable digital and technology-enabled businesses, is pleased to
Say tycoons hoping to make a fortune out of a booming British pot industry Britain could legalise cannabis in the next five years, say experts in the industryÂ
GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion